Literature DB >> 1712019

Elucidation of an essential structure recognized by an anti-GalNAc alpha-Ser(Thr) monoclonal antibody (MLS 128).

H Nakada1, Y Numata, M Inoue, N Tanaka, H Kitagawa, I Funakoshi, S Fukui, I Yamashina.   

Abstract

To determine the epitopic structure for an anti-GalNAc alpha-Ser(Thr) (anti-Tn) monoclonal antibody, MLS 128, asialo-ovine submaxillary mucin was digested with various proteases, and the digests were fractionated by immunoaffinity column chromatography and high performance liquid chromatography. From the tryptic digest, a glycopeptide, GP-I, and five other glycopeptides, GP-1-5, were obtained as bound and unbound fractions, respectively, of the immunoaffinity column. By solid phase radioimmunoassaying, it was found that GP-I was strongly immunoreactive, whereas GP-1-5 were poorly immunoreactive. On treatment with V8 protease, GP-I was converted to two glycopeptides, one with poor reactivity and the other with intermediate reactivity. From the thermolysin digest, the smallest fragment, GP-II, was isolated, which was as strongly immunoreactive as GP-I. GP-II corresponded to a part of GP-I, its sequence being Leu-Ser*-Glu-Ser*-Thr*-Thr*-Gln-Leu-Pro-Gly, where asterisks denote amino acids to which an alpha-GalNAc residue is attached. Other anti-Tn monoclonal antibodies, NCC-LU-35 and CA 3239, showed essentially the same reactivity to these glycopeptides as MLS 128 did. The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GalNAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)-Ser, and GalNAc-Thr-(GalNAc)-Thr. These results indicate that a glycopeptide including a cluster structure, Ser*-Thr*-Thr*, is an essential part of the epitope recognized by anti-Tn antibodies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712019

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells.

Authors:  Ola Blixt; Olga I Lavrova; Dmitriy V Mazurov; Emiliano Cló; Stjepan K Kracun; Nicolai V Bovin; Alexander V Filatov
Journal:  Glycobiology       Date:  2011-12-05       Impact factor: 4.313

2.  Carbohydrate specificity of an insecticidal lectin isolated from the leaves of Glechoma hederacea (ground ivy) towards mammalian glycoconjugates.

Authors:  Tanuja Singh; June H Wu; Willy J Peumans; Pierre Rougé; Els J M Van Damme; Richard A Alvarez; Ola Blixt; Albert M Wu
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

3.  Specificities of anti-sialyl-Tn and anti-Tn monoclonal antibodies generated using novel clustered synthetic glycopeptide epitopes.

Authors:  M A Reddish; L Jackson; R R Koganty; D Qiu; W Hong; B M Longenecker
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

4.  Distribution of Tn antigen recognized by an anti-Tn monoclonal antibody (MLS128) in normal and malignant tissues of the digestive tract.

Authors:  G Ohshio; T Imamura; M Imamura; H Yamabe; H Sakahara; H Nakada; I Yamashina
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

5.  Effects of hapten density on the induced antibody repertoire.

Authors:  Qian Li; Luis G Rodriguez; David F Farnsworth; Jeffrey C Gildersleeve
Journal:  Chembiochem       Date:  2010-08-16       Impact factor: 3.164

6.  Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa.

Authors:  S Ogata; R Koganty; M Reddish; B M Longenecker; A Chen; C Perez; S H Itzkowitz
Journal:  Glycoconj J       Date:  1998-01       Impact factor: 2.916

7.  Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128).

Authors:  H Nakada; M Inoue; Y Numata; N Tanaka; I Funakoshi; S Fukui; A Mellors; I Yamashina
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

8.  Specificity of human anti-carbohydrate IgG antibodies as probed with polyacrylamide-based glycoconjugates.

Authors:  E P Smorodin; O A Kurtenkov; B L Sergeyev; G V Pazynina; N V Bovin
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

9.  IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.

Authors:  Hitoshi Suzuki; Zina Moldoveanu; Stacy Hall; Rhubell Brown; Huong L Vu; Lea Novak; Bruce A Julian; Milan Tomana; Robert J Wyatt; Jeffrey C Edberg; Graciela S Alarcón; Robert P Kimberly; Yasuhiko Tomino; Jiri Mestecky; Jan Novak
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

10.  Coexpression of cancer-associated carbohydrate antigens, Tn and sialyl Tn.

Authors:  H Nakada; M Inoue; N Tanaka; I Yamashina
Journal:  Glycoconj J       Date:  1994-06       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.